我們已在上線! 進一步了解
ICUI圖示

ICU Medical

162.99 USD
-4.24
2.54%
收盤時 已更新 10月16日 下午4:00 EDT
盤前交易
盤後交易
162.99
0.00
0%
1天
-2.54%
5天
2.04%
1個月
4.74%
3個月
0.51%
6個月
29.32%
今年迄今
17.66%
1年
39.92%
5年
-27.69%
10年
11.72%
 

關於: ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

員工: 13,000

新聞

正面
中性
負面
市場情緒 3個月
正面 40%
中性 60%
負面 0%
正面
Zacks Investment Research
8 天前
3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
中性
Seeking Alpha
上個月
ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
中性
GlobeNewsWire
上個月
ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.
ICU Medical to Participate in Upcoming Investor Conferences
正面
Benzinga
2 個月前
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
中性
Seeking Alpha
2 個月前
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
正面
MarketBeat
2 個月前
ICU Medical Q2 Earnings Call Highlights
ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.
ICU Medical Q2 Earnings Call Highlights
中性
Zacks Investment Research
2 個月前
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
正面
Zacks Investment Research
2 個月前
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $2.1 per share a year ago.
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
中性
GlobeNewsWire
2 個月前
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2026.
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
中性
GlobeNewsWire
2 個月前
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2026 earnings release and conference call.
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
價格圖表採用Lightweight Charts™實作